Abstract
Aggressive treatment of localized hepatic metastases, by surgery or other means, was proven to be a viable strategy for improving the prognoses of many patients. In that context, thermal ablation by high intensity ultrasound was proposed and used in clinics. However, for treating deep-seated tumors and in most cases, radiofrequency and cryotherapy probes are applied interstitially. Interstitial ultrasound applicators were proposed as an intermediate solution. The treatment can be focused, deeper than with other physical agents, and the transducer can eventually both treat and image tissues. In our experience, two approaches were investigated: percutaneous and intratissular, or endo vascular. The active element was a miniature flat transducer operating at a frequency of 5 MHz, for a satisfactory tradeoff between beam penetration and energy absorption. In vivo trials on a porcine model demonstrated that both procedures are minimally invasive and that large thermal lesions, up to 20 mm deep, can be obtained. Technological improvements such as the use of dual mode transducers (for imaging and therapy) or the performance under MRI guidance allowed monitoring the treatment in real-time.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.